Bone Biologics (BBLG) Other Non Operating Income (2016 - 2018)

Bone Biologics (BBLG) has reported Other Non Operating Income for 3 consecutive years, with -$408294.0 the latest figure, recorded in Q3 2018.

• In Q3 2018, Other Non Operating Income rose 85.64% year-over-year to -$408294.0; the TTM figure through Dec 2018 stood at -$6.1 million (changed N/A YoY), while the FY2018 annual figure was -$408294.0, changed N/A from the prior year.
• Other Non Operating Income improved to -$408294.0 in Q3 2018 per BBLG's latest filing, from -$2.8 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at -$408294.0 in Q3 2018 and bottomed at -$2.8 million in Q1 2016.
• Historically, Other Non Operating Income has averaged -$2.5 million across 3 years, with a median of -$2.8 million in 2016.
• Annual changes were most pronounced in 2017 — Other Non Operating Income changed 0.0% — and 2018, when it jumped 85.64%.
• Bone Biologics' Other Non Operating Income stood at -$2.8 million in 2016, then changed by 0.0% to -$2.8 million in 2017, then surged by 85.64% to -$408294.0 in 2018.
• Business Quant data shows BBLG's Other Non Operating Income at -$408294.0 in Q3 2018, -$2.8 million in Q3 2017, and -$2.8 million in Q2 2017.